Pharming Group N.V. (ADR)
General ticker "PHAR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.0B (TTM average)
Pharming Group N.V. (ADR) follows the US Stock Market performance with the rate: 12.3%.
Estimated limits based on current volatility of 2.2%: low 12.87$, high 13.45$
Factors to consider:
- Earnings expected soon, date: 2026-07-30 bmo
- Total employees count: 229 as of 2020
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [14.23$, 25.26$]
- 2026-12-31 to 2027-12-31 estimated range: [14.20$, 25.16$]
Short-term PHAR quotes
Long-term PHAR plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $307.75MM | $376.13MM |
| Operating Expenses | $316.67MM | $355.25MM |
| Operating Income | $-8.93MM | $20.88MM |
| Non-Operating Income | $0.13MM | $-8.03MM |
| Interest Expense | $9.05MM | $10.72MM |
| R&D Expense | $86.10MM | $100.37MM |
| Income(Loss) | $-8.79MM | $12.85MM |
| Taxes | $0.00MM | $10.31MM |
| Net Income(Loss)* | $-12.26MM | $2.85MM |
| Stockholders Equity | $228.91MM | $277.02MM |
| Inventory | $57.70MM | $64.88MM |
| Assets | $414.18MM | $499.81MM |
| Operating Cash Flow | $-1.86MM | $50.07MM |
| Capital expenditure | $0.82MM | $0.75MM |
| Investing Cash Flow | $32.74MM | $18.43MM |
| Financing Cash Flow | $-35.63MM | $14.48MM |
| Earnings Per Share** | $-0.18 | $0.04 |
| Ordinary share to ADR | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.